The Centers for Disease Control and Prevention (CDC) will host a Clinician Outreach and Communication Activity (COCA) Webinar “Protecting Infants from Respiratory Syncytial Virus (RSV)” on October 26 from 2:00 – 3:00 p.m. ET. CDC subject matter experts will discuss the latest recommendations, clinical considerations, safety information, and other details for nirsevimab and the maternal RSV vaccine. Click here on the date and time of the webinar to join live. The webinar offers continuing education options, including CME and CNE. You do not have to attend the live session to qualify for CE. For more information about the webinar, click here. The American Academy of Pediatrics has several helpful resources regarding RSV including: Practice Readiness Checklist: Use this checklist to assess your practice’s readiness to administer nirsevimab to patients. Nirsevimab Implementation Guide: Use this guide as you roll out nirsevimab to patients. Nirsevimab Administration Visual Guide: Use this algorithm/guide to help determine if and what dose is needed for administration. Immunization Information Statement: Provide this VIS-like information to parents/caregivers when administering nirsevimab. Coding Guidance: Find information about the CPT codes for nirsevimab and its administration, including coding vignettes. Nirsevimab FAQs: Find answers to common questions about nirsevimab and administering it to patients. This page also includes a link to submit unanswered questions. AAP News Article, “Supply issues plague nirsevimab ordering” (October 17, 2023) AAP Chapter Immunization Representative: To locate your state’s CIR, please submit an inquiry to the Immunization FAQ Submission Form. | 
